Back
BioRestorative Therapies, Inc. 10K Form
Sell
13
BRTX
BioRestorative Therapies, Inc.
Last Price:
$1.11
Seasonality Move:
-2.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BRTX News And Ratings
See the #1 stock for the next 7 days that we like better than BRTX
BRTX Financial Statistics
Sales & Book Value
| Annual Sales: | $401K |
|---|---|
| Cash Flow: | $-2.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.27 |
| Price / Book: | 4.45 |
Profitability
| EPS (TTM): | -1.51260 |
|---|---|
| Net Income (TTM): | $-12.7M |
| Gross Margin: | $183.9K |
| Return on Equity: | -199.72% |
| Return on Assets: | -123.4% |
BioRestorative Therapies, Inc. Earnings Forecast
Key BioRestorative Therapies, Inc. Financial Ratios
-
The Gross Profit Margin over the past 16 years for BRTX is 45.86%.
-
The Selling, General & Administrative Expenses for BRTX have been equal to 1,640.75% of Gross Profit Margin.
-
The Research & Development expenses have been 1,333.84% of Revenue.
-
The Net Earning history of BRTX is -2,239.25% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 11 years.
BioRestorative Therapies, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BRTX |
| Website: | biorestorative.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.37 |
| Quick Ratio: | 1.31 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BRTX Technical Analysis vs Fundamental Analysis
Sell
13
BioRestorative Therapies, Inc. (BRTX)
is a Sell
Is BioRestorative Therapies, Inc. a Buy or a Sell?
-
BioRestorative Therapies, Inc. stock is rated a SellThe current BioRestorative Therapies, Inc. [BRTX] share price is $1.10. The Score for BRTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.